This program supports the creation of a prototype Open Knowledge Network — an interconnected network of knowledge graphs supporting a very broad range of application domains. Open access to shared ...

Okasan Securities Group Inc. Annual stock financials by MarketWatch. View the latest OKN financial statements, income statements and financial ratios.

PRINCETON, NJ, and OKLAHOMA CITY, OK--(Marketwired - February 15, 2016) - GtreeBNT Co., Ltd., has entered into an agreement with the Oklahoma Medical Research Foundation (OMRF) to acquire the rights ...

Please provide your email address to receive an email when new articles are posted on . OKN-007 received FDA fast track designation for the treatment of children with diffuse intrinsic pontine glioma, ...

OKN-007 is being evaluated both alone and in combination with chemotherapy for patients with glioma or glioblastoma — both types of brain cancer. Patients can now enroll in a phase 1 clinical trial ...

Oblato plans to evaluate OKN-007 for diffuse intrinsic pontine glioma in a phase 1/2 trial this year. The Food and Drug Administration (FDA) has fast tracked an investigational therapy for diffuse ...

Below is a summary assembled by the Research & Innovation Office (RIO). Please see the full solicitation for complete information about the funding opportunity. This ...